(Q40371959)

English

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer

scientific article published on 9 December 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

metastatic breast cancer

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Richard E Champlin

10

object named as

Richard E Champlin

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

9

object named as

Sergio A Giralt

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

8

object named as

Issa F Khouri

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

4

object named as

John D McMannis

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Gabriela Rondon

2

object named as

Gabriela Rondón

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Yee Chung Cheng

1

object named as

Yee Chung Cheng

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Leah F Sanchez

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Daniel R Couriel

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Marcos J de Lima

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Naoto T Ueno

11

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

publication date

9 December 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

International Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

627-634

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with interleukin-2 and alpha-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and onl

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose consolidation therapy with autologous stem cell rescue in stage IV breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new protocol for the propagation of dendritic cells from rat bone marrow using recombinant GM-CSF, and their quantification using the mAb OX-62

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced IL-2 level concentration in patients with breast cancer as a possible risk factor for relapse

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy for breast cancer: the French PEGASE experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study evaluating interleukin-2-activated hematopoietic stem cell transplantation for hematologic malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-s

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot study of immunotherapy with interleukin-2 after autologous stem cell transplantation in advanced breast cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic peripheral-blood progenitor-cell transplantation for poor-risk patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chem

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood lymphocytes from patients with cancer lack interleukin-2 receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular interaction against autologous tumor cells between IL-2-cultured lymphocytes and fresh peripheral blood lymphocytes in patients with breast cancer given immuno-chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma - a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction, mobilization of peripheral blood stem cells (PBSC), high-dose chemotherapy and PBSC infusion in patients with untreated stage IV breast cancer: outcomes by intent to treat analyses

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting outcome based on Swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19998065

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12185-009-0439-6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40371959&oldid=2203638533"